Our TechnologyThe SaNP (Sarah Nanoparticles)New Phase has developed a promising therapeutic technology based on hyperthermiaIn general, cancer cells exposed to temperatures between 41°C to 45°C are more sensitive to heat than normal cells, mainly due to the complexity of the vascular architecture in solid tumors. Tumor cells with a disorganizedvascular structure, unlike normal cells, have difficulty dissipating heat, because of their inability to increase blood flow in response to heat.
Sarah Nanotechnology comprises of a new type of super-paramagnetic iron oxide nanoparticles developed and patented by New Phase.
IBX Price at posting:
6.8¢ Sentiment: Hold Disclosure: Held
